# Coherent Sine Burst (CSE) Electroporation System Pilot Study in Patients With Atrial Fibrillation

Study · id `cardio:ct-nct05572047` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05572047](<https://clinicaltrials.gov/study/NCT05572047>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05572047

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 101 participants.

## Technical summary

Registry record NCT05572047. Allocation not applicable; no masking; primary purpose treatment. Start 2022-10-11 (actual); primary completion 2026-04-24 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 101 participants (enrolled count; ClinicalTrials.gov record NCT05572047, source copy `cardio:ctgov-nct05572047-2026-10-28`, retrieved 2026-10-31)
- Started: 2022-10-11 (actual) (ClinicalTrials.gov record NCT05572047, source copy `cardio:ctgov-nct05572047-2026-10-28`, retrieved 2026-10-31)
- Primary completion: 2026-04-24 (actual) (ClinicalTrials.gov record NCT05572047, source copy `cardio:ctgov-nct05572047-2026-10-28`, retrieved 2026-10-31)
- Completion: 2026-04-24 (actual) (ClinicalTrials.gov record NCT05572047, source copy `cardio:ctgov-nct05572047-2026-10-28`, retrieved 2026-10-31)
- Countries: Croatia; Georgia (ClinicalTrials.gov record NCT05572047, source copy `cardio:ctgov-nct05572047-2026-10-28`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05572047-2026-10-28`, retrieved 2026-10-31)

## The registry's words

- Brief title: Coherent Sine Burst (CSE) Electroporation System Pilot Study in Patients With Atrial Fibrillation
- Acronym: BURST-AF
- Condition: Atrial Fibrillation
- Intervention (Device): Arga Medtech Coherent Sine-Burst Electroporation (CSE) Ablation System
- Lead sponsor: Arga Medtech SA
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)

## Provenance

Content hash: 82b84a39ac2fffb768b34f9a714f59e11b3276f8122b1bfc8440480d8719d469
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
